Skip to main content
Article thumbnail
Location of Repository

Functional bowel disease : a challenging frontier in gastroenterology

By Michael Camilleri


The last 30 years have seen incredible advances in the science and practice of gastroenterology and hepatology. In the 1970s, the fiberoptic endoscopic revolution facilitated the visualization of the mucosa of a large segment of the gastrointestinal tract and afforded the opportunity for specialized studies using histological and biochemical analyses. The impact of fiberoptic endoscopy on surveillance or screening for cancer of the colon will be more apparent in the next millennium. Novel pharmacological approaches have had a dramatic impact on gastroenterology

Topics: Gastroenterology, Digestive organs -- Diseases, Gastrointestinal system -- Diseases
Publisher: Maltese Medical Journal
Year: 1999
OAI identifier:
Provided by: OAR@UM

Suggested articles


  1. A pilot study of motility and tone of the left
  2. (1991). Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsia. The irritable stomach syndrome. Dig Dis Sci doi
  3. (1997). Adrenergic modulation of human colonic motor and sensory function. doi
  4. (1989). Bemier 11. Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind, placebo-controlled evaluation of cisapride. Dig Dis Sci doi
  5. (1993). Biofeedback training in disordered defecation . A critical review. Dig Dis Sci doi
  6. (1997). Clinical economics review: irritable bowel syndrome. Aliment Pharmacol Ther doi
  7. (1997). Clinical response to dietary fiber treatment of chronic constipation.
  8. (1997). Colonic transit scintigraphy labeled activated charcoal compared with ion exchange pellets.
  9. Development of a test to measure gastric accommodation in humans.
  10. (1992). Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology doi
  11. (2000). Functional digestive disorders (FDD) in the year doi
  12. (1999). Gastric accommodation in nonulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function. doi
  13. Gastric and autonomic responses to stress in functional dyspepsia. doi
  14. (1993). householder survey of functional gastrointestinal disorders: prevalence, sociodemography and health impact. Dig Dis Sci doi
  15. HTF919, a partial 5HT4 agonist, accelerates small bowel transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterology 1999; 116:A I066. doi
  16. (1996). Hyperventilation alters colonic motor and sensory function: effects and mechanisms in humans. Gastroenterology doi
  17. (1999). Impaired drinking capacity in a subgroup of functional dyspeptic patients. Gastroenterology doi
  18. Improvement in pain and bowel function in female M. Camilleri14 irritable bowel patients with alosetron, a 5HT3-receptor antagonist. Aliment Pharmacol Ther doi
  19. (1997). Irritable bowel syndrome: a technical review for practice guideline development. doi
  20. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. doi
  21. (1998). lanssens 1. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology doi
  22. (1995). Medical costs in community subjects with irritable bowel syndrome. Gastroenterology doi
  23. (1994). Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. doi
  24. (1999). Modulation of gastric sensory and motor functions by nitrergic and alpha-2 adrenergic agents. in humans. Gastroenterology doi
  25. (1999). Motor function in irritable bowel syndrome. doi
  26. (1991). Neurohormonal factors in functional dyspepsia: insights on pathophysiologic mechanisms. Gastroenterology doi
  27. (1996). Nonulcer dyspepsia: a look into the future. Mayo Clin Proc doi
  28. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. doi
  29. (1995). Psychosensory modulation of colonic sensation in the human transverse and sigmoid colon. Gastroenterology doi
  30. Regional cerebral activity in normal and pathological perception of visceral pain. doi
  31. (1999). Reproducibility of a water load test in healthy subjects and symptom profile compared to patients with functional dyspepsia. Gastroenterology
  32. (1998). Review article: colonic sensorimotor physiology in health and its alteration in constipation and diarrheal disorders. Aliment Pharn1acol Ther doi
  33. (1996). Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology doi
  34. (1999). Selective stimulation of colonic transit-by the benzofuran 5HT4 agonist, prucalopride, in healthy humans. doi
  35. (1994). Serotonergic mediation of postprandial colonic tonic and phasic responses in humans. doi
  36. Simplified assessment of segmental colonic transit. doi
  37. (1998). Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. doi
  38. (1998). The influence of cisapride on gastric tone and the perception of gastric distension. Aliment Pharmacol Ther doi
  39. The irritable colon syndrome. A study of the clinical features, predisposing causes, and prognosis in 130 cases.
  40. (1999). The kappa agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome. doi
  41. (1991). The origin of symptoms on the brain-gut axis in functional dyspepsia. Gastroenterology doi
  42. (1999). The role of psychological and biological factors in postinfective gut dysfunction. doi
  43. (1992). Transit through the proximal colon influences stool weight in the irritable bowel syndrome. Gastroenterology doi
  44. (1999). Treatment of female IBS patients with alosetron, a potent and selective 5HT3 receptor antagonist. Gastroenterology doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.